低血压训练与卡路里限制改善脂质概况和肥胖相关的高胆固醇血症男性的身体组成:一个受控干预研究研究
Emil Jędrzejewski1, Miłosz Czuba2, Adam Niemaszyk2
1Warsaw Southern Hospital, 02-781 Warsaw, Poland.
International journal of molecular sciences
|November 27, 2025
概括
间歇性缺氧训练 (IHT) 与卡路里限制饮食相结合,显著改善了脂质概况,并比超重男性的标准训练更多地减少了身体脂肪. 这表明IHT是管理与肥胖相关的高胆固醇血症的有希望的工具.
科学领域:
- 运动生理学 运动生理学
- 代谢健康 代谢健康
- 心血管疾病风险因素 心血管疾病风险因素
背景情况:
- 肥胖和高胆固醇是心血管疾病的关键风险因素.
- 传统的生活方式干预措施在改善脂质概况方面表现出有限的有效性.
- 间歇性缺氧训练 (IHT) 是一种新兴的代谢增强策略.
研究的目的:
- 评估一个为期4周的强化IHT计划加上卡路里限制对脂质概况和身体组成的影响.
- 在超重/肥胖和高胆固醇血症的男性中,比较IHT与normoxic训练的影响.
主要方法:
- 20名身体不活跃的男性被随机分配到低氧 (H) 或正常氧 (C) 控制组.
- 两组人都接受了相同的训练方案和卡路里限制饮食4周.
- 在干预前和后测量身体组成,休息代谢率和血脂 (TC,HDL-C,LDL-C,非HDL-C,TG).
主要成果:
- 与对照组相比,IHT组显示身体质量 (-5.4%) 和脂肪质量 (-14.7%) 的减少明显更大.
- IHT导致总胆固醇 (-22.6%),LDL-C (-25.8%),非HDL-C (-26.5%),TG (-31.4%) 的显著降低,并改善了血的动脉动脉指数.
- 没有观察到HDL-C的显著变化;对照组只显示了非显著的趋势.
结论:
- 将IHT与饮食限制相结合,可以在脂质配置和身体成分方面取得优异的改善,而不是normoxic训练.
- IHT为管理与肥胖相关的高胆固醇血症提供了一种对传统生活方式干预措施有前途的补充方法.
- 对IHT在心血管风险管理中的作用进行进一步研究是有必要的.
相关概念视频
Atherosclerosis III: Management
301
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
301
Cholesterol: Significance and Regulation
1.2K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
1.2K
Blood Studies for Cardiovascular System III: Serum Lipid Profile
537
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
537
Coronary Artery Disease IV: Preventive Measures
577
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
577
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.3K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
228
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
228


